See what your peers are saying about the iovera° technology.

Scott Sigman, MD

Lowell, Massachusetts

2018

"As a member of (Massachusetts) Governor Baker’s Special Commission to establish a pain management program, I have been an opioid-sparing surgeon for over 5 years. To that extent, I use all available options to help my patients avoid opioids after major orthopedic surgery. The iovera° technology is one such tool. My total knee patients who receive the iovera° therapy use significantly fewer opioids than those that didn’t. The iovera° treatment is now considered a standard of care in my patients who are having a total knee replacement surgery."

Joshua A. Urban, MD

Omaha, Nebraska

2018

"The iovera° technology (system) has significantly changed the way I treat patients with chronic or acute knee pain in my practice. It has reduced opioid consumption in these patients after surgery. Treatment with the iovera° system has helped me buy time in my chronic pain patients, and in patients who are not eligible for surgery. I have developed an ultrasound imaging procedure that has helped me better target the nerves that are contributing to my patients’ knee pain."

Pieter Vreede, MD

Noblesville, Indiana

2017

“I’ve been using iovera° technology for the last several months and am thrilled with the outcomes I’ve seen thus far. This technology is providing a significant non-opioid and non-systemic option for my patients suffering from knee pain.”

Vinod Dasa, MD

New Orleans, Louisiana

2016

“This technology has allowed us to change our entire pain management protocol for TKAs; reducing the number of opioids needed post-surgery and enhancing our physical therapy protocols are just two of the resulting benefits.”

IndicationThe iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. The iovera° system’s “1x90” Smart Tip configuration (indicating one needle which is 90 mm long) can also facilitate target nerve location by conducting electrical nerve stimulation from a separate nerve stimulator.

Important Safety Information

ContraindicationsThe iovera° system is contraindicated for use in patients with the following:

  • Cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud’s disease, and open and/or infected wounds at or near the treatment site

Potential ComplicationsAs with any surgical treatment that uses needle-based therapy and local anesthesia, there is a potential for site-specific reactions, including, but not limited to:

  • Ecchymosis, edema, erythema, local pain and/or tenderness, and localized dysesthesia

Proper use of the device as described in the User Guide can help reduce or prevent the following complications :

  • At the treatment site(s): injury to the skin related to application of cold or heat, hyper- or hypopigmentation, and skin dimpling
  • Outside the treatment site(s): loss of motor function
SEE MORE

The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain.

Important Safety Information